| Nov 25 | Feb 26 | May 26 | Aug 26 | |||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Buy | — | — | — | — | — | — | — | — | — | — | — | — |
| Sell | — | — | — | — | — | — | — | — | — | — | — | — |
| 2023 | 2024 | 2025 | Q'26 | |
|---|---|---|---|---|
| Cash | 0.70 | 4.64 | 0.62 | 0.74 |
| Receivables | 10.44 | 2.82 | 4.26 | 11.73 |
| Inventory | 0.69 | 0.88 | 1.31 | 3.22 |
| Other | 8.48 | 7.97 | 14.62 | 32.75 |
| 20.31 | 16.34 | 20.84 | 48.51 |
| 2023 | 2024 | 2025 | Q'26 | |
|---|---|---|---|---|
| Payables | 0.55 | 0.91 | 1.80 | 3.11 |
| ST’ Debt | — | — | — | — |
| Other | — | — | — | — |
| 39.93 | 18.69 | 3.36 | 28.82 |
| 10y | 5y | 3y | |
| Sales | — | — | ‡‡‡‡‡ |
| Cash Flow | — | — | ‡‡‡‡‡ |
| Earnings | — | — | ‡‡‡‡‡ |
| Book Value | — | — | ‡‡‡‡‡ |
| Mar | Jun | Sep | Dec | Year | |
|---|---|---|---|---|---|
| ’26 | 11.58 | 24.04 | — | — |
—
|
| ’25 | 8.67 | 10.74 | 4.79 | 10.55 |
34.76
|
| ’24 | 12.79 | 10.83 | 9.27 | 9.41 |
42.30
|
| ’23 | 3.15 | 1.70 | 10.11 | 13.78 |
28.74
|
| ’22 | 1.36 | — | — | — |
3.29
|
| Mar | Jun | Sep | Dec | Year | |
|---|---|---|---|---|---|
| ’26 | 9.28 | 3.55 | — | — |
—
|
| ’25 | 3.29 | (0.35) | 2.48 | (1.43) |
4.00
|
| ’24 | 14.79 | 6.60 | (1.18) | 4.76 |
24.98
|
| ’23 | 0.71 | 0.99 | 3.70 | 0.24 |
5.64
|
| ’22 | 2.31 | — | — | 1.05 |
1.05
|
| Mar | Jun | Sep | Dec | Year | |
|---|---|---|---|---|---|
| ’26 | 9.28 | 3.55 | — | — |
—
|
| ’25 | 3.29 | (0.51) | 2.48 | (1.43) |
3.84
|
| ’24 | 7.99 | 11.78 | (1.18) | 4.76 |
23.35
|
| ’23 | 0.71 | 0.99 | (0.60) | 0.24 |
1.34
|
| ’22 | 2.31 | — | — | (38.34) |
(38.34)
|
| Mar | Jun | Sep | Dec | Year | |
|---|---|---|---|---|---|
| ’26 | (53.20) | 79.52 | — | — |
—
|
| ’25 | 56.02 | (49.19k) | 2.46k | 1.65k |
1.11k
|
| ’24 | 93.26k | (238.61k) | 840.17 | (52.76k) |
(144.17k)
|
| ’23 | (0.04) | (924.18k) | 1.26m | 2.10m |
5.29m
|
| 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| — | — | — | — | — | — | — | 3,040,800.00 | 46,200.00 | 1,120.00 | — | — | — |
Low Price
|
| — | — | — | — | — | — | — | 168,000,000.00 | 5,754,000.00 | 53,760.00 | — | — | — |
High Price
|
| — | — | — | — | — | — | — | — | — | — | — | — | — |
Employees
|
| — | — | — | — | — | ‡‡‡ | 0.00 | 0.00 | 0.00 | 0.00 | — | — | — |
Revenue/Emp
|
| — | — | — | — | — | ‡‡‡‡‡ | 3.29 | 28.74 | 42.30 | 34.76 | — | — | — |
Revenue
|
| — | — | — | — | — | ‡‡‡‡‡ | 57.59% | 56.76% | 46.82% | 36.87% | — | — | — |
Gross Margin
|
| — | — | — | — | — | ‡‡‡‡‡ | 0.55 | 9.29 | (2.75) | 10.47 | — | — | — |
EBT
|
| — | — | — | — | — | ‡‡‡‡‡ | 16.78% | 32.33% | (6.50%) | 30.13% | — | — | — |
EBT Margin
|
| — | — | — | — | — | ‡‡‡‡‡ | 0.55 | 9.29 | (2.75) | 10.47 | — | — | — |
Net Income
|
| — | — | — | — | — | ‡‡‡‡‡ | 0.56 | 4.10 | 6.18 | 6.50 | — | — | — |
Depreciation
|
| — | — | — | — | — | ‡‡‡‡‡ | 0.00 | 0.00 | 422,961.00 | 115,852.00 | — | — | — |
Revenue/Sh
|
| — | — | — | — | — | ‡‡‡‡ | — | 13,190,640.00 | (144,172.80) | 13,112.04 | — | — | — |
Earnings/Sh
|
| — | — | — | — | — | ‡‡‡‡‡ | 0.00 | 0.00 | 249,761.00 | 13,339.33 | — | — | — |
Cash Flow/Sh
|
| — | — | — | — | — | ‡‡‡ | 0.00 | 0.00 | (16,231.00) | (539.67) | — | — | — |
Capex/Sh
|
| — | — | — | — | — | ‡‡‡‡‡ | 0.00 | 0.00 | 233,530.00 | 12,799.67 | — | — | — |
Free CF/Sh
|
| — | — | — | — | — | ‡‡‡‡‡ | 0.00 | 0.00 | 713,613.00 | 316,998.67 | — | — | — |
Book Value/Sh
|
| — | — | — | — | — | ‡‡‡‡‡ | 0.00 | 0.00 | 0.00 | 0.00 | — | — | — |
Shares
|
| — | — | — | — | — | ‡‡‡‡‡ | 1.41 | 0.56 | 0.00 | 0.03 | — | — | — |
PE Ratio
|
| — | — | — | — | — | ‡‡‡ | 0.00 | 0.00 | 0.11 | 0.01 | — | — | — |
PS Ratio
|
| — | — | — | — | — | ‡‡‡ | 0.00 | 0.00 | 0.07 | 0.00 | — | — | — |
PB Ratio
|
| — | — | — | — | — | ‡‡‡ | 0.00 | (0.02) | 0.00 | (0.01) | — | — | — |
EV/Sales
|
| — | — | — | — | — | ‡‡‡ | 0.00 | (0.12) | 0.01 | (0.06) | — | — | — |
EV/FCF
|
| — | — | — | — | — | ‡‡‡‡‡ | 1.05 | 5.64 | 24.98 | 4.00 | — | — | — |
Op' Cash Flow
|
| — | — | — | — | — | ‡‡‡‡‡ | (39.39) | (4.30) | (1.62) | (0.16) | — | — | — |
Capex
|
| — | — | — | — | — | ‡‡‡‡‡ | (38.34) | 1.34 | 23.35 | 3.84 | — | — | — |
FCF
|
| — | — | — | — | — | ‡‡‡‡‡ | 0.06 | (19.62) | (2.35) | 17.48 | — | — | — |
Working Cap'
|
| — | — | — | — | — | ‡‡‡‡‡ | — | — | — | — | — | — | — |
Total Debt
|
| — | — | — | — | — | ‡‡‡‡‡ | — | (0.70) | (4.64) | (0.62) | — | — | — |
Net Debt
|
| — | — | — | — | — | ‡‡‡‡‡ | 38.89 | 55.54 | 71.36 | 95.10 | — | — | — |
Sh' Equity
|
| — | — | — | — | — | ‡‡‡ | 1.96% | 12.60% | (8.26%) | 4.20% | — | — | — |
ROA
|
| — | — | — | — | — | ‡‡‡ | 0.89% | 11.88% | 9.43% | 0.90% | — | — | — |
ROIC
|
| — | — | — | — | — | ‡‡‡ | 2.32% | 18.06% | (12.75%) | 5.03% | — | — | — |
ROE
|
C3is Inc. (CISS), a micro-cap dry bulk shipping play, exemplifies cyclical volatility: revenue plunged 48% in 2022 before surging 774% to $28.7M in 2023 and another 47% to $42.3M in 2024, driven by Ukraine war rerouting and charter rate spikes. Yet profitability flipped from $9.3M EBT profit in 2023 to a $2.8M loss in 2024 amid gross margins eroding to 46.8%, highlighting operational leverage in a capital-intensive sector marred by reverse splits that distorted per-share metrics.
The cash flow story steals the show—operating cash flow exploded 443% to $25M in 2024, yielding $23.4M free cash flow despite non-cash depreciation hits, with ROIC at a solid 9.4%. Balance sheet fortification shines: net cash position, shareholders’ equity up 715% to $71M, and debt eliminated, creating a rare negative EV (-4.6% of sales).
Trading at ~$1.51 with PS 0.06, PB 0.04, and EV/FCF -0.08—implying 95-97% undervaluation versus book or FCF—CISS screams speculative turnaround potential (1,200%+ upside on PB normalization). No analyst targets or insider trades amplify retail risk/reward in stabilizing shipping cycles, but net cash cushions downturns—dive deeper for the full quant breakdown.
Keep track of companies that you follow and research.
Full access to our data with predictions and indicators that we calculate daily.
Full access to our screener with tons of custom values and customizable email notifications.
Excel export of financials and screeners you define and save.